Abstract

V-ATPases are multimeric proton pumps. The 100-kDa "a" subunit is encoded by four isoforms (a1-a4) in mammals and two (Vph1p and Stv1p) in yeast. a3 is enriched in osteoclasts and is essential for bone resorption, whereas a4 is expressed in the distal nephron and acidifies urine. Mutations in human a3 and a4 result in osteopetrosis and distal renal tubular acidosis, respectively. Human a3 (G405R and R444L) and a4 (P524L and G820R) mutations were recreated in the yeast ortholog Vph1p, a3 (G424R and R462L), and a4 (W520L and G812R). Mutations in a3 resulted in wild type vacuolar acidification and growth on media containing 4 mM ZnCl2, 200 mM CaCl2, or buffered to pH 7.5 with V-ATPase hydrolytic and pumping activity decreased by 30-35%. Immunoblots confirmed wild type levels for V-ATPase a, A, and B subunits on vacuolar membranes. a4 G812R resulted in defective growth on selective media with V-ATPase hydrolytic and pumping activity decreased by 83-85% yet with wild type levels of a, A, and B subunits on vacuolar membranes. The a4 W520L mutation had defective growth on selective media with no detectable V-ATPase activity and reduced expression of a, A, and B subunits. The a4 W520L mutation phenotypes were dominant negative, as overexpression of wild type yeast a isoforms, Vph1p, or Stv1p, did not restore growth. However, deletion of endoplasmic reticulum assembly factors (Vma12p, Vma21p, and Vma22p) partially restored a and B expression. That a4 W520L affects both Vo and V1 subunits is a unique phenotype for any V-ATPase subunit mutation and supports the concerted pathway for V-ATPase assembly in vivo.

Highlights

  • V-ATPases are complexes composed of at least 13 different subunits

  • Identical to wild type Vph1p pRS316_VPH1_G812R (MM322 used as backbone with MO30 and MO155 with MO154 and T7 and MO30 and T7) pRS316_VPH1 ϩ SacI site_R462L (MM623 used as backbone with MO23 and MO157 plus MO156 and T7 and MO23 plus T7) pRS316_VPH1 ϩ SacI site_W520L (MM623 used as backbone MO23 and MO161 and MO160 and T7, plus MO23 and T7) pRS316_VPH1 ϩ SacI site_G424R (MM623 used as backbone MO23 and MO159 and MO158 and T7 plus MO23 and T7)

  • To investigate the effect of human a3 and a4 mutations that lead to recessive malignant osteopetrosis and distal renal tubule acidosis (dRTA), we recreated four missense mutations as follows: two a3 and two a4 in conserved residues of the yeast ortholog Vph1p

Read more

Summary

EXPERIMENTAL PROCEDURES

Materials—Escherichia coli and yeast culture media were purchased from Difco. Stevens (University of Oregon), and a serum against Vma22p was the kind gift from Dr Antony A. The PCR product was cut with EcoRI and NotI and cloned into pRS316 from MM322 cut with EcoRI and NotI. The PCR product was cut with SacI and cloned into pRS316 from MM623 cut with SacI. For VPH1 mutation G424R, first round PCR primers were MO23 and MO159 with T7 and MO158. The PCR product was cut with SacI and cloned into pRS316 from

Yeast strain
This study
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call